Implementation of PPACA.
Patent Reform Act and Patent Trademark Office Fee Modernization Act.
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. The Ryan White CARE Act AIDS Drug Assistance Programs (ADAP) in the FY2011 Labor, Health & Human Services and Education appropriations bill. Senate Special Committee on Aging Letter of Inquiry on Drug Pricing.
HR4213 American Jobs and Closing Tax Loopholes Act
Duration: January 1, 2008
to
June 30, 2010
General Issues: Health Issues , Copyright/Patent/Trademark , Medicare/Medicaid , Taxation/Internal Revenue Code , Defense , Medical/Disease Research/Clinical Labs
Spending: about $400,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: House of Representatives, U.S. Senate,, U.S. Senate, Health & Human Services - Dept of (HHS), Commerce - Dept of (DOC), White House Office, Executive Office of the President (EOP), White House Office,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Cecil Swamidoss
Legal Intern, US Sen. Spec. Cmte on Aging (1998);
Deputy Inv., US Sen. Spec. Cmte on Aging (1999-
2001); Inv. Counsel, US Sen. Cmte on Finance
(2001); Inv. Counsel US Sen. Spec. Cmte On Aging
(2001-2003); Senior Counsel, US Sen. Spec. Cmte
Aging (2004-2008).
Cecil Swaimdoss
Legal Intern, US Sen. Spec. Cmte on Aging (1998);
Deputy Inv., US Sen. Spec. Cmte on Aging (1999-
2001); Inv. Counsel, US Sen. Cmte on Finance
(2001); Inv. Counsel US Sen. Spec. Cmte On Aging
(2001-2003); Senior Counsel, US Sen. Spec. Cmte
Aging (2004-2008).
Judith Lemons
Chief of Staff, Congresswoman Nancy Pelosi.
Cartier Esham
n/a
Darren Willcox
n/a
n/a n/a
n/a
Gary Andres
n/a
Gray Andres
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2010
DUTKO WORLDWIDE, LLC terminated an engagement in which they represented GLAXOSMITHKLINE on July 14, 2010.
Original Filing: 300286661.xml
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
Patent Reform Act and Patent Trademark Office Fee Modernization Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. The Ryan White CARE Act AIDS Drug Assistance Programs (ADAP) in the FY2011 Labor, Health & Human Services and Education appropriations bill. Senate Special Committee on Aging Letter of Inquiry on Drug Pricing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Lobbying Issues
HR4213 American Jobs and Closing Tax Loopholes Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on April 5, 2010.
Original Filing: 300254481.xml
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. The Ryan White CARE Act AIDS Drug Assistance Programs (ADAP) in the FY2011 Labor, Health & Human Services and Education appropriations bill. Senate Special Committee on Aging Letter of Inquiry on Drug Pricing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Fair Prescription Drug Competition Act (S. 501) & Preserve Access to Affordable Generics Act (S.369). The Ryan White CARE Act AIDS Drug Assistance Programs (ADAP) in the FY2011 Labor, Health & Human Services and Education appropriations bill. Senate Special Committee on Aging Letter of Inquiry on Drug Pricing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2009
In Q4, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on Dec. 31, 2009.
Original Filing: 300227009.xml
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Health Issues Medicare/Medicaid
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200),Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Fair Prescription Drug Competition Act (S. 501) & Preserve Access to Affordable Generics Act (S.369).
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2009
In Q3, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on Oct. 1, 2009.
Original Filing: 300199905.xml
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices
Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark(no bill number assigned). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Health Issues Copyright/Patent/Trademark Medicare/Medicaid
2nd Quarter, 2009
In Q2, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on July 9, 2009.
Original Filing: 300174100.xml
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Health Issues Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to medicare and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
1st Quarter, 2009
In Q1, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on April 9, 2009.
Original Filing: 300145422.xml
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
Type of Issue
Health Issues Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to medicare and other health care issues and advise client as it affects them, including Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate,
4th Quarter, 2008
In Q4, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on Jan. 7, 2009.
Original Filing: 300114195.xml
Lobbying Issues
Monitor legislation pertaining to pharmaceuticals and vaccine issues and advise client as it affects them, including, Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008
(HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007, (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White), Pharmaceutical import safety legislation (bill number not assigned yet).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Commerce - Dept of (DOC) White House Office
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including
Medicare Improvements for Patients and Providers Act of 2008 (S 3101),Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007(HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Health & Human Services - Dept of (HHS)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Tricare, including Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Health & Human Services - Dept of (HHS)
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United State Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Executive Office of the President (EOP)
3rd Quarter, 2008
In Q3, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on Oct. 8, 2008.
Original Filing: 300089227.xml
Lobbying Issues
Monitor legislation pertaining to pharmaceuticals and vaccine issues and advise client as it affects them, including, Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007, (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White), Pharmaceutical import safety legislation (bill number not assigned yet).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Commerce - Dept of (DOC) White House Office
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including
Medicare Improvements for Patients and Providers Act of 2008 (S 3101),Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007(HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Health & Human Services - Dept of (HHS)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Tricare, including Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Health & Human Services - Dept of (HHS)
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2007 (HR1908/S1145), Pathway for Biosimilars Act (HR5629), Tom Lantos and Henry J. Hyde United State Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (HR5501), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312) FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Executive Office of the President (EOP)
2nd Quarter, 2008
In Q2, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on July 8, 2008.
Original Filing: 300061588.xml
Lobbying Issues
Monitor legislation pertaining to pharmaceuticals and vaccine issues and advise client as it affects them, including Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007, (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White), Pharmaceutical import safety legislation (bill number not assigned yet)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) Commerce - Dept of (DOC) White House Office
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including
Medicare Improvements for Patients and Providers Act of 2008 (S 3101),Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007(HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Health & Human Services - Dept of (HHS)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Tricare, including Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate White House Office Health & Human Services - Dept of (HHS)
1st Quarter, 2008
DUTKO WORLDWIDE, LLC amended a lobbying report for representation of GLAXOSMITHKLINE in Q12008 on April 9, 2008.
Original Filing: 300034262.xml
Lobbying Issues
Monitor legislation pertaining to pharmaceuticals and vaccine issues and advise client as it affects them, including Medicare Reform Legislation, Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office,
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Medicare Reform Legislation, Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Commerce - Dept of (DOC)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Tricare, including Medicare Reform Legislation, Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
1st Quarter, 2008
In Q1, DUTKO WORLDWIDE, LLC lobbied for GLAXOSMITHKLINE , earning $40,000. The report was filed on April 7, 2008.
Original Filing: 300032824.xml
Lobbying Issues
Monitor legislation pertaining to pharmaceuticals and vaccine issues and advise client as it affects them, including Medicare Reform Legislation, Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office,
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them, including Medicare Reform Legislation, Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office Commerce - Dept of (DOC)
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to Tricare, including Medicare Reform Legislation, Budget resolution FY2009 (H.Con.Res.312), Patent Reform Act of 2007 (HR1908/S1145), Appropriations Bill: Labor, HHS FY 09 (Ryan White).
Agencies Lobbied
U.S. House of Representatives U.S. Senate Health & Human Services - Dept of (HHS) White House Office
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate